Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity
- PMID: 7828340
- DOI: 10.1111/j.1365-2265.1994.tb01816.x
Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity
Abstract
Endocrine autoimmunity is known to be characterized by the presence of specific autoantibodies and from the histopathological point of view by lymphocytic infiltration in the target tissue. The presence of mononuclear cell infiltrates is the pathological hallmark of most endocrine diseases characterized by an autoimmune process directed against antigens expressed on endocrine cells. Infiltrating cells can usually be detected by biopsy or by using other, non-invasive, techniques. However, in endocrine tissue such as the islets of Langerhans and the adrenal glands it is difficult to perform biopsies and diagnosis of the autoimmune process is dependent mainly upon detection of specific autoantibodies. A crucial aspect of endocrine autoimmunity and of all processes of organ specific autoimmunity is why and how lymphocytes migrate from primary lymphoid tissue to their specific targets. This occurs mainly through contact with specific adhesion molecules which enable lymphocytes to adhere to the endothelial vessels in close proximity to the target tissue. In this review we discuss the homing of peripheral mononuclear cells into target endocrine tissues and the mediating role of adhesion molecules.
Similar articles
-
Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice.J Immunol. 1994 Jun 15;152(12):5969-78. J Immunol. 1994. PMID: 8207221
-
Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues.Science. 1983 Apr 15;220(4594):304-6. doi: 10.1126/science.6301002. Science. 1983. PMID: 6301002
-
Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?Springer Semin Immunopathol. 2002 Dec;24(3):297-321. doi: 10.1007/s00281-002-0110-2. Springer Semin Immunopathol. 2002. PMID: 12503056 Review.
-
Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.J Autoimmun. 1995 Apr;8(2):209-20. doi: 10.1006/jaut.1995.0016. J Autoimmun. 1995. PMID: 7612149
-
Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?Springer Semin Immunopathol. 2002 Dec;24(3):261-71. doi: 10.1007/s00281-002-0109-8. Springer Semin Immunopathol. 2002. PMID: 12503054 Review.
Cited by
-
Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).Clin Exp Immunol. 1998 Aug;113(2):309-14. doi: 10.1046/j.1365-2249.1998.00658.x. Clin Exp Immunol. 1998. PMID: 9717983 Free PMC article.
-
The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.Clin Exp Immunol. 2002 May;128(2):308-12. doi: 10.1046/j.1365-2249.2002.01818.x. Clin Exp Immunol. 2002. PMID: 11985521 Free PMC article.
-
Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease.Oncotarget. 2016 Nov 29;7(48):78680-78687. doi: 10.18632/oncotarget.12019. Oncotarget. 2016. PMID: 27637079 Free PMC article.
-
Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.J Endocrinol Invest. 1999 Jun;22(6):430-5. doi: 10.1007/BF03343586. J Endocrinol Invest. 1999. PMID: 10435852 Clinical Trial.
-
Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves' disease.Endocrine. 2015 Sep;50(1):123-9. doi: 10.1007/s12020-015-0552-7. Epub 2015 Mar 15. Endocrine. 2015. PMID: 25771884
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical